SCHEMBL6380853

SCHEMBL6380853

CC(C)(C)OC(=O)N1C[C@H](OCc2ccc3ccccc3c2)CC1C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BDKRB2 P30411 2/20 0.48
MC4R P32245 4/20 0.45
MC3R P41968 4/20 0.45
MC1R Q01726 4/20 0.45
MCL1 Q07820 4/20 0.44
ABCB1 P08183 1/20 0.44
SLC6A2 P23975 3/20 0.42
SLC6A4 P31645 3/20 0.42
SLC6A3 Q01959 3/20 0.42
HTR2A P28223 1/20 0.42
HTR2C P28335 1/20 0.42
HTR7 P34969 1/20 0.42
HTR2B P41595 1/20 0.42
HTR3A P46098 1/20 0.42
HTR4 Q13639 1/20 0.42
UCHL1 P09936 1/20 0.42
AGTR2 P50052 2/20 0.41
KCNH2 Q12809 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6380846 1.00 BDKRB2 (0.48) BDKRB2MC4RMC3RMC1RMCL1
SCHEMBL6380857 1.00 BDKRB2 (0.48) BDKRB2MC4RMC3RMC1RMCL1
SCHEMBL26604823 0.88 ABCB1 (0.52) BDKRB2MCL1ABCB1UCHL1AGTR2
SCHEMBL3179881 0.88 ABCB1 (0.52) BDKRB2MCL1ABCB1UCHL1AGTR2
SCHEMBL708630 0.88 ABCB1 (0.52) BDKRB2MCL1ABCB1UCHL1AGTR2
SCHEMBL376159 0.88 ABCB1 (0.52) BDKRB2MCL1ABCB1UCHL1AGTR2
SCHEMBL1448119 0.88 ABCB1 (0.52) BDKRB2MCL1ABCB1UCHL1AGTR2
SCHEMBL7287734 0.88 ABCB1 (0.52) BDKRB2MCL1ABCB1UCHL1AGTR2
SCHEMBL949983 0.88 ABCB1 (0.52) BDKRB2MCL1ABCB1UCHL1AGTR2
SCHEMBL708628 0.88 ABCB1 (0.52) BDKRB2MCL1ABCB1UCHL1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1003775-B1 HEPATITIS C INHIBITOR PEPTIDES BOEHRINGER INGELHEIM CA LTD (CA) 2005-03-16 EP disclosed
US-6767991-B1 PEPTIDES AND ANALOGS THEREOF; VIRAL PROTEASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH PEPTIDES AND RIBAVIRIN BOEHRINGER INGELHEIM (CANADA) LTD. (CA) 2004-07-27 US disclosed